You are here

Publications

Sort By:

2014
Menon S, Dibble CC, Talbott G, Hoxhaj G, Valvezan AJ, Takahashi H, Cantley LC, Manning BD.  2014.  Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome.. Cell. 156(4):771-85.
Mayer IA, Abramson VG, Isakoff SJ, Forero A, Balko JM, Kuba MGabriela, Sanders ME, Yap JT, Van den Abbeele AD, Li Y et al..  2014.  Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.. J Clin Oncol. 32(12):1202-9.
Lyssiotis CA, Cantley LC.  2014.  Targeting metabolic scavenging in pancreatic cancer.. Clin Cancer Res. 20(1):6-8.
González-Billalabeitia E, Seitzer N, Song SJung, Song MSup, Patnaik A, Liu X-S, Epping MT, Papa A, Hobbs RM, Chen M et al..  2014.  Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.. Cancer Discov. 4(8):896-904.
2013
Wu N, Zheng B, Shaywitz A, Dagon Y, Tower C, Bellinger G, Shen C-H, Wen J, Asara J, McGraw TE et al..  2013.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.. Mol Cell. 49(6):1167-75.
Anaesth BJ.  2013.  Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar.
Carracedo A, Cantley LC, Pandolfi PPaolo.  2013.  Cancer metabolism: fatty acid oxidation in the limelight.. Nat Rev Cancer. 13(4):227-32.
Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, Wang G, Mazzucchelli R, Bianconi M, Stack EC et al..  2013.  A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.. Nat Genet. 45(7):747-55.
Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LCGonzalez, Lannon WA, Grotzinger C, Del Rio M et al..  2013.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.. Nat Med. 19(5):619-25.
Emerling BM, Hurov JB, Poulogiannis G, Tsukazawa KS, Choo-Wing R, Wulf GM, Bell EL, Shim H-S, Lamia KA, Rameh LE et al..  2013.  Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.. Cell. 155(4):844-57.
Shinoda G, Shyh-Chang N, T de Soysa Y, Zhu H, Seligson MT, Shah SP, Abo-Sido N, Yabuuchi A, Hagan JP, Gregory RI et al..  2013.  Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism.. Stem Cells. 31(8):1563-73.
Yeo H, Lyssiotis CA, Zhang Y, Ying H, Asara JM, Cantley LC, Paik J-H.  2013.  FoxO3 coordinates metabolic pathways to maintain redox balance in neural stem cells.. EMBO J. 32(19):2589-602.
Son J, Lyssiotis CA, Ying H, Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N et al..  2013.  Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway.. Nature. 496(7443):101-5.
Hu J, Locasale JW, Bielas JH, O'Sullivan J, Sheahan K, Cantley LC, Heiden MGVander, Vitkup D.  2013.  Heterogeneity of tumor-induced gene expression changes in the human metabolic network.. Nat Biotechnol. 31(6):522-9.
Davis MI, Sasaki AT, Shen M, Emerling BM, Thorne N, Michael S, Pragani R, Boxer M, Sumita K, Takeuchi K et al..  2013.  A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.. PLoS One. 8(1):e54127.
Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H, Choo-Wing R, Bellinger G, Tsukazawa KS, Brown V et al..  2013.  Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients.. Proc Natl Acad Sci U S A. 110(9):3483-8.
Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng Y, Teo RYi, Ratanasirintrawoot S, Zhang J, Onder T, Unternaehrer JJ, Zhu H et al..  2013.  Influence of threonine metabolism on S-adenosylmethionine and histone methylation.. Science. 339(6116):222-6.
Shyh-Chang N, Zhu H, T de Soysa Y, Shinoda G, Seligson MT, Tsanov KM, Nguyen L, Asara JM, Cantley LC, Daley GQ.  2013.  Lin28 enhances tissue repair by reprogramming cellular metabolism.. Cell. 155(4):778-92.
Liu Y, Marks K, Cowley GS, Carretero J, Liu Q, Nieland TJF, Xu C, Cohoon TJ, Gao P, Zhang Y et al..  2013.  Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.. Cancer Discov. 3(8):870-9.
Kim SGyun, Hoffman GR, Poulogiannis G, Buel GR, Jang YJin, Lee KWon, Kim B-Y, Erikson RL, Cantley LC, Choo AY et al..  2013.  Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex.. Mol Cell. 49(1):172-85.
Lyssiotis CA, Cantley LC.  2013.  Metabolic syndrome: F stands for fructose and fat.. Nature. 502(7470):181-2.
Fendt S-M, Bell EL, Keibler MA, Davidson SM, Wirth GJ, Fiske B, Mayers JR, Schwab M, Bellinger G, Csibi A et al..  2013.  Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.. Cancer Res. 73(14):4429-38.
Song SJung, Poliseno L, Song MSup, Ala U, Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC et al..  2013.  MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.. Cell. 154(2):311-24.
Csibi A, Fendt S-M, Li C, Poulogiannis G, Choo AY, Chapski DJ, Jeong SMin, Dempsey JM, Parkhitko A, Morrison T et al..  2013.  The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4.. Cell. 153(4):840-54.
Lyssiotis CA, Son J, Cantley LC, Kimmelman AC.  2013.  Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance.. Cell Cycle. 12(13):1987-8.

Pages